Ä¢¹½Ö±²¥

Prostate screening does more harm than good in US

Preventive Services Task Force says screening for prostate-specific antigen "has no net benefit"

Doctors should stop screening for prostate cancer because it does more harm than good. This advice comes more than a decade after the prostate-specific antigen (PSA) test was introduced in the US.

“PSA-based screening for prostate cancer has no net benefit,� concludes the , which evaluates screening services. The dangers of PSA-based screening include a high rate of false positives, negative psychological effects, and complications associated with diagnostic biopsy and treatment, the task force says.

Between 1986 and 2005, 1 million men in the US had surgery and radiotherapy for prostate cancer after a PSA test, but the panel found no evidence this prevented more deaths than “watching and waiting�. However, between 200 and 300 men in every thousand treated developed incontinence or erectile dysfunction.

“It’s encouraging to see a real debate on the impact of the PSA test on patient outcome,� says of Eastern Virginia Medical School in Norfolk.

“I think their decision is premature because there’s more data coming in on whether screening is beneficial or not,� says of the University of Oxford, chief investigator of the UK ProtecT study, which is investigating the issue.

, director of the clinical prostate cancer programme at Northwestern University in Chicago, agrees: “PSA is the best screening test we have for prostate cancer, and until there is a replacement, it would be unconscionable to stop it,� he says.

Topics: Cancer